Idorsia Ltd
Biopharmaceutical company developing small-molecule medicines for multiple therapeutic areas.
IDIA | SW
Overview
Corporate Details
- ISIN(s):
- CH0363463438 (+2 more)
- LEI:
- 506700XOVZUB107S5720
- Country:
- Switzerland
- Address:
- Hegenheimermattweg 91, 4123 Allschwil
- Website:
- https://www.idorsia.com/index
- Sector:
- Manufacturing
Description
Idorsia Ltd is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative small-molecule medicines. The company maintains a diversified and balanced clinical development pipeline targeting multiple therapeutic areas. These areas include central nervous system (CNS) disorders, cardiovascular conditions, immunological diseases, and orphan diseases. Idorsia's objective is to develop new products that can significantly alter treatment options in their target indications. A key commercialized product is a dual orexin receptor antagonist for the treatment of insomnia.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Idorsia Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Idorsia Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Idorsia Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-05-11 | N/A | Non-Executive member | Buy | None | 98,179.90 CHF |
| 2022-05-10 | N/A | Non-Executive member | Buy | None | 109,660.30 CHF |
Peer Companies
